Gavan, Sean P. http://orcid.org/0000-0003-3659-056X
Wright, Stuart J. http://orcid.org/0000-0002-4064-7998
Thistlethwaite, Fiona http://orcid.org/0000-0002-4832-7008
Payne, Katherine http://orcid.org/0000-0002-3938-4350
Funding for this research was provided by:
Innovate UK (104234)
Article History
Accepted: 19 December 2022
First Online: 11 March 2023
Declarations
:
: Sean P. Gavan and Katherine Payne declare that they have no conflict of interest. Stuart J. Wright reports consultancy fees for acting on a steering group for a project investigating the impact of including supply constraints in economic evaluations for PHMR on a project funded by Roche. Fiona Thistlethwaite reports institutional research grant income from Instil Bio; honoraria from GSK, Bristol Myers Squibb, Janssen, and Pfizer; advisory committee membership for Immatics; and speaker fees from Kite/Gilead; is principal investigator for commercial ATMP trials (Adaptimmune, GSK, T-knife Therapeutics, Instil Bio), but does not receive personal payment; and is director of iMATCH (Innovate Manchester Advanced Therapy Centre Hub), supported by Innovate UK.
: This work was supported by Innovate UK (grant number 104234). For the purpose of open access, the authors have applied a Creative Commons Attribution (CC BY) licence to any Author Accepted Manuscript version arising.
: All data generated or analysed during this study are included in this published article (and its supplementary information files).
: Not applicable.
: Not applicable.
: Not applicable.
: Not applicable.